Target validation of acid-sensing ion channel inhibitors to stop disease progression and manage pain in MS (2023–2026)

Grant type:
National Multiple Sclerosis Society-US
Researchers:
  • Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
    Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
  • Honorary Senior Research Fellow
    School of Biomedical Sciences
    Faculty of Medicine
  • Emeritus Professor
    School of Biomedical Sciences
    Faculty of Medicine
  • Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
National Multiple Sclerosis Society-US